GAVISCONPRO MENTHE 1000 mg/200 mg/10 ml, suspension buvable

Business Listing - September 04, 2021

GAVISCONPRO MENTHE 1000 mg/200 mg/10 ml, suspension buvable

GAVISCONPRO MENTHE 1000 mg/200 mg/10 ml, suspension buvable suspension buvable orale Autorisation active Procédure de reconnaissance mutuelle Non commercialisée 10/18/2006 RECKITT BENCKISER HEALTHCARE FRANCE

Tags & Categories

active autorisation procédure orale suspension buvable reconnaissance mutuelle menthe gavisconpro

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business